One member of the ADAM family, A disintegrin and metalloproteinase 10 (ADAM10), has been reported to act as a positive regulator of cancer progression in hepatocellular carcinoma (9), renal cell carcinoma (10), pancreatic carcinoma (11), lung cancer (12) and gastric carcinoma (13). This evidence concerns the gene ADAM10 and cancer.